scholarly journals Growth differentiation factor‐15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM‐HF trial

2018 ◽  
Vol 20 (12) ◽  
pp. 1701-1709 ◽  
Author(s):  
Nadia Bouabdallaoui ◽  
Brian Claggett ◽  
Michael R. Zile ◽  
John J.V. McMurray ◽  
Eileen O'Meara ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Growth Differentiation Factor 15 ◽  
Reduced Ejection Fraction ◽  
Differentiation Factor ◽  
Patients With Heart Failure ◽  
Independent Marker

scholarly journals Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction

2015 ◽  
Vol 18 (1) ◽  
pp. 81-88 ◽  
Author(s):  
Michelle M.Y. Chan ◽  
Rajalakshmi Santhanakrishnan ◽  
Jenny P.C. Chong ◽  
Zhaojin Chen ◽  
Bee Choo Tai ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Growth Differentiation Factor 15 ◽  
Reduced Ejection Fraction ◽  
Differentiation Factor

scholarly journals Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction

2020 ◽  
Vol 7 (5) ◽  
pp. 2223-2229
Author(s):  
Ana Belen Mendez Fernandez ◽  
Andreu Ferrero‐Gregori ◽  
Alvaro Garcia‐Osuna ◽  
Sonia Mirabet‐Perez ◽  
Maria Jose Pirla‐Buxo ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Growth Differentiation Factor 15 ◽  
Reduced Ejection Fraction ◽  
Heart Failure Patients ◽  
Differentiation Factor
Sign in / Sign up

Export Citation Format

Share Document